| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 7,899 | 7,594 | 9,470 | 12,389 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 7,899 | 7,594 | 9,470 | 12,389 | | | Operating Expenses | | Research Development | 9,920 | 9,362 | 10,462 | 11,063 | | Selling General and Administrative | (3,756) | 2,938 | 6,817 | 3,206 | | Non Recurring | 1 | 441 |
-
| 72,000 | | Others | 982 | (491) | (491) | (491) | | | | Total Operating Expenses | 7,147 | 12,250 |
-
| 85,778 | | | | Operating Income or Loss | 752 | (4,656) | (7,318) | (73,389) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 320 | 223 | 30 | (509) | | Earnings Before Interest And Taxes | 1,072 | (4,433) | (7,288) | (73,898) | | Interest Expense | 21 | 42 | 194 | 66 | | Income Before Tax | 1,051 | (4,475) | (7,482) | (73,964) | | Income Tax Expense |
-
|
-
|
-
| (234) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,051 | (4,475) | (7,482) | (73,730) | | | Non-recurring Events | | Discontinued Operations | 6,671 | 2,807 | 2,366 | 4,103 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,800 | (1,668) | (5,116) | (69,627) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,800 | ($1,668) | ($5,116) | ($69,627) |
|
0.50% Nasdaq 0.00%
Income Statement
